• Nem Talált Eredményt

also definition also definition

N/A
N/A
Protected

Academic year: 2022

Ossza meg "also definition also definition"

Copied!
19
0
0

Teljes szövegt

(1)

A AB, see 4-Aminoazobenzene

Abstinence syndrome, definition of, 246 Acaprine, resistance to, 78

4-Acetamido-3-chlorobenzene stibonic acid, see Stibosan

Acetate, requirement for, 356

4-Acetylaminobiphenyl, carcinogenesis, and, 289-290

2-Acetylaminoflourene, carcinogenesis and, 304

N-Acetylarsanilic acid, resistance to, 66, 71

Acetylcholine, brain and, 221 narcotics and, 212

Acetylcholinesterase, morphine and, 257 Acetylkynurenine, accumulation of, 355 Acetylmethylcarbinol, proflavine adapta­

tion and, 47

Acridines, see also Acriflavine, Proflavine mutations and, 379-380

resistance to, 71, 376-377 trypanosomes and, 62 yeast enzymes and, 388 Acriflavine, see also Acridines

cytochrome oxidase and, 379-380 mitochondria and, 410

nucleic acids and, 47 parabasal body and, 380 resistance to, 65, 66, 93, 425

antagonism of, 68, 69 mechanism, 92-93 p-rosaniline and, 70 trypanosomes and, 343 yeast and, 343

ACTH, see Adrenocorticotropic hormone Adenine, requirement for, 357

pH and, 398 temperature and, 399 Adenocarcinomas,

azaguanine and, 277 mercaptopurine and, 279

Adenosine, mercaptopurine and, 280 Adenosine triphosphate, 220, 221

carcinogens and, 294

narcotics and, 213-214, 265-266 potassium and, 218

Adenylic acid, azaguanine and, 280 Adrenal glands,

alcohol and, 184-188 coat color and, 412 morphine and, 231, 252

Adrenocorticotropic hormone, tumor transplants and, 320

Aerobacter aerogenes, 88 drug resistance of, 28, 378-379 polymixin resistant, 391-393 proflavine adaptation and, 43-59 Alanine, 372

fluorophenylalanine and, 367 Alcohol,

adrenal glands and, 184-188 anoxia and, 209

brain respiration and, 219-220 consumption, variation in, 203 glycogen and, 189

metabolism, habit formation and, 2 0 5 - 206

potassium and, 219-220 spiders and, 420 Alcoholism,

ascorbic acid and, 187-188 definition of, 194

diet and, 189-193, 203-208 glucose and, 189

metabolic differences and, 205 proneness, 195, 413

Aldolase,

drug resistance and, 395 morphine and, 231 variations in, 200 Aldrin,

metabolism of, 140 resistance to, 148, 155

Alfalfa mosaic virus, nucleoprotein of, 372

(2)

N-Allynormorphine, 254

abstinence syndrome and, 247-248 diuresis and, 252

enzymes and, 414

morphological changes and, 259, 260 Alpha-peltatin, leukemias and, 271, 273 A-methopterin,

combination therapy with, 283-284 cross-dependence and, 278

dependence, 270-277 formate incorporation and, 276 leukemias and, 268-269

purine analog resistance and, 282-284, 342

Amino acids,

blood, variations in, 197 inhibition by, 358

tobacco mosaic virus and, 372 Aminoacridine, oxidation of, 384 5-Aminoacridine,

resistance to, 45

4-Amino-6- (2'-amino-6'-methylpyrimidyl- 4'-amino) quinaldine-l:l dimetho salt, see Antrycide

4-Aminoazobenzene, carcinogenesis and, 289 methylation of, 293 p-Aminobenzoic acid, 3

drug antagonism of, 77

drug resistance and, 69, 384, 397 requirement for, 398

2-Amino-4,6-bis (4-amino-2-methyl-6- quinolylamino)-s-triazine, see Surfen C

2-Amino-5-dimethylaminodiphenylamine, carcinogenesis and, 291

4-Amino-9,N10-dimethylpteroylglutamic acid, see A-denopterin

4-Amino-5-imidazolecarboxamide, strep­

tomycin and, 388

4-Amino-N10-methylpteroylglutamic acid, see A-methopterin

2-Amino-l-naphthol, carcinogenesis and, 289

p-Aminophenol, excretion of, 295 p-(2-Aminopropyl) phenol, see Paredrine Aminopterin,

resistance, 341, 342

utilization of, 274-275

4-Aminopteroylglutamic acid, see Amin­

opterin

Aminoquinolines, resistance to, 73 p-Aminosalicylic acid,

bacterial mitosis and, 87 isoniazid and, 36 resistance to, 10, 34

Aminotriazole, translocation of, 107 Amphetamine, tolerance to, 229-230, 249 Amylase,

herbicides and, 109, 111 variations in, 200

Anemone Pulsatilla, variations in, 177 Anhydrides, hypersensitivity and, 401 Aniline, carcinogens and, 295 Anoxia, 410

alcohol and, 209 Antabuse, 3, 191

Anthranilic acid, accumulation of, 355 Antibody, 417

altered protein and, 400 drug resistance and, 72-73 tumors and, 326-328 Anticholinesterase, 142 Antigens, tumors and, 328-329 Antrycide, resistance to, 62, 66, 67 Arabinose, adaptation, proflavine and, 4 7 -

48

Arginase, variations in, 200 Arginine,

influenza virus and., 372 requirement for, 360-361 Arsenic,

detoxification of, 139 excretion of, 138

resistance, 62, 97, 135, 138, 172, 178, 379

antagonism to, 68 human, 233 spontaneous, 71

Arsenite, resistance to, 65, 284, 378 Arsonic acids, resistance to, 65 Arsenophenylglycine,

resistance to, 64-65, 66 antagonism, 69

Arsenosobenzenebutyric acid, antagonism of, 69

(3)

Arsenosobenzenes, resistance to, 65 Arsphenamine, resistance to, 66 Ascorbic acid, 203

adrenal, alcohol and, 184, 188 genes and, 196

oxidation, herbicides and, 111 Asparagine,

bacterial enzymes and, 394 fluorophenylalanine and, 367

Aspartic acid, streptomycin and, 94-95, 387, 389, 390, 391

Atabrine, dehydrogenases and, 396 Atoxyl, resistance to, 65

Aureomycin,

antagonism to, 383 penicillin and, 383 resistance to, 35, 78, 382 Autocatalysis, 417-418 Avena, see Oats 8-Azaguanine,

A-methopterin and, 342

combination therapy with, 283-284 cross-dependence and, 278 deamination of, 281, 415 dependence, 278-289

folic analogs and, 282-284 incorporation of, 280-281 leukemias and, 271, 273, 277-278 resistance, 278-279

folic analogs and, 282-284 reversal of, 280

8-Azazanthine,

cross-dependence and, 278 tumor sensitivity and, 281 Azide,

morphine and, 260 nerve activity and, 265 oxygen uptake and, 258 resistance, 31, 34,

inheritance of, 9 Β

Babesia canis, drug resistance of, 78 Bacillus megaterium,

drug combinations and, 36 drug resistance in, 34 mitosis, antibiotics and, 86, 87 Bacillus subtilis, enzymes of, 393-394

Bacitracin,

antagonism to, 383 cross-resistance and, 379 Bacteria,

colonies, heterogeneity of, 374r-376 genes of, 5

mutations, deleterious, 11 variation, resistance and, 339-340 Bacteriophage,

drug resistance and, 32 lysogenic, 32, 33

resistance to, 9, 11, 34, 89, 381 clonal, 31

frequency, 14 origin, 56-57 radiation and, 423-424 streptomycin and, 17

Bacterium lactis aerogenes, see Aerobac- ter aerogenes

Barbital, excretion of, 235-236 Barbiturates,

acetylation and, 212

brain respiration and, 211-212, 266 cross-tolerance and, 229

phosphorylation and, 214 skin and, 418

tolerance to, 239 Barley,

herbicides and, 111, 112 mutants of, 8

Bed bugs, resistance of, 98 Bees, disease resistance of, 135 Beetles,

resistance of, 98, 158 modification of, 177

3,4-Benzpyrene, carcinogenesis and, 304 N-Benzylmethylaminoazobenzene, carcin­

ogenesis and, 289 Biotin, requirement for, 357

3-4'-Bis (acetamido) -2'-carboxymethoxy- 4-hydroxy arsenobenzene, see Solu- salvarsan

1,1-Bis (p-chlorophenyl) -2,2-dichloro- ethylene, see DDE

l,l-Bis( p-chlorophenyl) -methyl carbinol, see DMC

1,1-Bis (p-chlorophenyl) -2,2,2-trichloro- ethane, see DDT

(4)

Blood, groups, 201

hydration, morphine and, 231 morphine concentration in, 236-237 pressure, morphine and, 225-226 Bodo, drug resistance of, 78

Boric acid, herbicide translocation and, 107

Brain, fuel of, 210 morphine and, 259

concentrations, 236-237 respiration, 209-210

alcohol and, 219-220

barbiturates and, 211-212, 266 malonate and, 218

tumor transplants and, 316, 317 Brassica alba, herbicides and 103 Brilliant green,

colony form and, 49, 50 fluctuation test and, 54 resistance, 91,

agar and, 48-49 development of, 51-52 Bromides, excretion of, 235 Buckwheat, herbicides and, 108 Butarsen, resistance to, 65, 66

C

Caffeine, tolerance to, 229, 249 Calcium, morphine and, 231 Camphor, mitosis and, 86 Carbohydrate,

brain activity and, 264 herbicides and, 105, 108-109 utilization, drug resistance and, 63 Carbon dioxide, 2,4-dichlorophenoxy-

acetic acid and, 113-114

2-Carboxymethylmercaptobenzene stibon- ic acid, resistance to, 65

Carcinogenesis,

altered protein and, 403-405 biochemical changes and, 301-302 mechanism of, 302-305

Carcinogens, enzymes and, 302 metabolism of,

demethylation, 293-295

over-all, 293

protein binding, 296-301 reduction, 295-296

structural requirements for, 288-291 Carcinoma, drug resistant, 284 Casein, bacterial enzymes and, 394 Catalase,

herbicides and, 111 nitrogen and, 394 proflavine and, 47 variations in, 200

Catenulin, cross-resistance and, 381 Cells, environment and, 418

Cerebrum, removal, drug addiction and, 414

Chaconines, 127 constitution of, 125 larvae and, 131 properties of, 125-126 Chemotherapy, multiple, 40 Chloramphenicol,

antagonism to, 383 colony form and, 49 fluctuation test and, 54 penicillin and, 383

resistance to, 10, 32, 35, 91-92, 376, 382

development of, 51, 56 replica plating and, 57 resting cells and, 85 stability, 48

Chlorate, plant respiration and, 110 Chlordane,

detoxification of, 139, 140 resistance to, 98,140, 148, 155 Chloretone, 220

acetylation and, 212 brain and, 211, 415 potassium and, 215-217 synaptic transmission and, 214 Chloromycetin, see Chloramphenicol 4-Chlorophenoxyacetic acid, activity of,

116

3- (p-Chlorophenyl) -1,1 -dimethyl urea, translocation of, 104

2-p-Chlorophenylguanidino-4-/?-diethyl- amino-6-methylpyrimidine hydro­

chloride, Paludrine resistance and, 75

(5)

N'-p-Chlorophenyl-NMsopropylbiguanide, see Paludrine

N^p-Chlorophenyl-N^methyl-N^isopro- pylbiguanide, Paludrine resistance and, 74

Chlorophyll, 419 streptomycin and, 410

N1-5-Chloro-2-pyrimidyl metanilamide, see Metachloridine

Chlortetracycline, see Aureomycin Cholesterol, adrenal, alcohol and, 184-

188 Choline,

aminoazobenzenes and, 294 morphine and, 256

Cholinesterase, antagonists of, 141 variations in, 200

Chromosomes, non-disjunction, 362 Cinnamycin, resistance to, 34 Circulin, cross-resistance and, 379

Citrovorum factor, dependent leukemias and, 273-274

Citrulline, urinary, alcoholism and, 205 CMU, see 3- (Chlorophenyl) -1,1 -dimethyl

urea

Coagulase, drug resistance and, 376 Coca, chewing, diet and, 202 Cocaine, tolerance to, 229-230, 249 Cockroach,

arsenic detoxification and, 139 chlordane resistant, 140 DDT toxicity and, 137-138 resistance of, 98, 142

Codeine, enzyme action and, 238 Codling moth,

arsenic resistance, 135, 138, 172 resistance of, 97, 98

Colchicine, 7 mitosis and, 86, 87 resistance to, 78, 284

Colpidium, saponin resistance of, 177 Constipation, morphine and, 225 Convolvulus arvensis, herbicides and, 107,

108

Corn, herbicides and, 108, 112-113, 115 Cortisone,

leukemias and, 273

tumor transplants and, 319-320, 344 Cotton, herbicides and, 113

CPT, drug resistance and, 75 Crystal violet,

cross-resistance to, 379 resistance to, 45 Cyanide,

glycolysis and, 386 morphine and, 260

resistance to, 97, 135, 137, 142, 172 Cysteine,

drug resistance and, 68 streptomycin and, 387, 389 Cysteinylgylcinase, 372 Cytochrome, 343, 420

acridines and, 47, 388 inheritance and, 363 morphine and, 260 Cytochrome oxidase, acridines and, 388

drug resistance and, 142-143 morphine and, 231

mutations and, 379-380 Cytochrome c reductase,

acridines and, 388 carcinogens and, 302, 404 morphine and, 231, 257

Cytoplasm, inheritance and, 32-33, 3 6 2 - 364, 426-427

D

2,4-D, see 2,4-Dichlorophenoxyacetic acid DAB, see 4-Dimethylaminoazobenzene Dalapon, translocation of, 107

Dandelion, herbicides and, 103, 108, 110 Daraprim,

Paludrine resistance and, 75, 76 resistance to, 76, 77-78

Dauermodifikationen, 2, 26, 33, 378 loss of, 39

DDE,

DDT and, 156, 158

detoxification and, 140-141, 149, 150 DDT,

cytochrome oxidase and, 142-143 detoxification of, 139-141, 149, 162 diiodo analogue of, 154

penetration of, 136-137

(6)

resistance to, 98,122,135-136,137,148 mechanisms, 163

natural, 158

nerve activity and, 141-142 solvents and, 161-162 DDT-dehydrochlorinase, 415, 420

distribution of, 152-153 glutathione and, 150 inhibition of, 163 lice and, 156-157 sources of, 150-152 specificity of, 154-156 susceptible flies and, 153-154 Decarboxylase, nitrogen and, 394 Dehydrogenases,

acridines and, 46-47, 91-92, 93, 410 atabrine and, 396

drug resistance and, 63

5-Dehydroshikimic acid, inhibition and, 357-358

Demissidine, tomatidine and, 129 Demissine, 160

composition of, 127-128 larvae and, 124, 127 Deoxyribonucleic acid,

bacterial, 8

drug resistance and, 32 dyes and, 380

influenza virus and, 372 proflavine and, 47

Diabetes, oxygen uptake and, 210 Diamidines, resistance to 66, 67, 78 2,8-Diaminoacridine, see Proflavine 2,4-Diamino-5-p-chlorophenyl-l: 6-dihy-

dro-6:6-dimethyl-l: 3:5-triazine, see CPT

2,4-Diamino-5- (p-chlorophenyl) -6-ethyl- pyrimidine, see Daraprim

2,7-Diamino-10-methyl-9-phenylphenan- thridinium bromide, see Dimidium 2-4-Diaminopteridines, Paludrine and, 75,

76

2,6-Diaminopurine,

cross-dependence and, 278 incorporation of, 281 leukemias and, 273

1,2,5,6-Dibenzanthracene, carcinogenesis and, 304

2,4-Dichlorophenol, respiration and, 110 2,6-Dichlorophenoxyacetic acid, 99, 100,

420

activity of, 116 inhibition of, 116

mechanism of action, 115-117 metabolism of,

respiration, 113-114 transformation, 114-115 penetration of, 101-102, 112

pH and, 103 temperature and, 102 phloem and, 104-106 plant responses to, 107-113 resistance to, 115, 117

α,α'-Dichloropropionic acid, see Dalapon Dieldrin,

metabolism of, 140 resistance to, 148

DDT-dehydrochlorinase and, 155 Diet,

coca chewing and, 202

disease resistance and, 339-340, 346 sugar consumption and, 202 tumors and, 345

2,6-Difluoro-4-dimethylaminoazobenzene, carcinogenesis and, 290-291 3,5-Difluorotyrosine, resistance to, 367 Diguanidines, resistance to, 66 Dihydrostreptomycin, cross-resistance

and, 379

3,3'-Dihydroxybenzidine, carcinogenesis and, 289

4-Dimethylaminoazobenzene, carcinogenesis and, 287-288 demethylation of, 289, 293

derivatives, carcinogenesis and, 2 8 9 - 291

metabolism of, 403-404 protein and, 296-301, 415 reduction of, 295

N,N-Dimethyl-p-phenylenediamine, car­

cinogenesis and, 295 Dimidium, resistance to, 66, 67 Dinito-o-sec-butyl phenol, translocation

and, 106

3?5-Dinito-o-cresol, toxicity of? 103

(7)

2,4-Dinitrophenol, narcotics and, 214, 215 respiration and, 110

brain, 219, 220

Diphosphopyridine nucleotide, carcino­

gens and, 294, 295 Disease,

infectious, control strategy, 334-340 natural resistance to, 338-340 Dithienylbutenylamines, morphine toler­

ance and, 228 Diuresis,

methylxanthines and, 229 morphine and, 225, 252 DMC, detoxification and, 140 Dreft, herbicides and, 101

Drosophila, DDT resistance and, 163-164 Drugs,

mutation rate and, 25 resistance,

absorption and, 63, 136-137, 158, 384, 385

adaptation and, 385-386, 415-416 antagonism of, 67-70, 383-384 antigenicity and, 64

behavior and, 135-136, 157-158, 161 by-pass mechanisms and, 142-143 colony form and, 49-50

control of, 39-40, 336-340 definition of. 373

detoxification and, 139-141, 384, 415 development of, 4-5, 21-30, 82 enzymes and 385-386, 396-398 excretion and, 138-139 fluctuation test and, 52-54 genetics and, 31, 134 growth rate and, 82-83, 90 loss of, 37-39

mechanisms, 2-3, 70-73, 77, 9 2 , 1 3 4 - 135, 157-158, 426-428 medium and, 27-30, 392-395 mutation and, 5, 83, 409, 415-416 nutrition and, 377-378

origin of, 50-52 patterns of, 34-37, 384 predisposition to, 381-383 reproducibility, 380 resting-cells and, 83-85

sensitivity and, 141-142, 381 specificity of, 64-67

storage and, 137-138 structure and, 136 test for, 54-58

responses, variations in, 201-202 tolerance, 223-224

Ε

Embryo, tumor transplantation and, 316 Emesis, morphine and, 225, 227

Emetine, resistance to, 78 Emulsin, 126, 130

2,4-dichlorophenoxyacetic acid and, 115

Endamoeba histolytica, drug resistance of, 78, 430

Enzymes, 417

adaptive, 1-2, 6, 88, 419

drug resistance and, 380, 396-398 herbicides and, 111-112

proflavine adaptation and, 43-44, 4 7 - 48

zinc and, 2

Epidermis, plant, structure of, 100-101 Epilachna varivestis, see Beetles Epinephrine,

morphine and, 252-253, 266 resistance to, 414

Equine encephalomyelitis virus, 372 Erythrocytes, tumor immunity and, 329 Erythromycin,

bacterial mitosos and, 87 resistance to, 34 Escherichia coli,

azide resistant, 31

bacteriophage resistant, 31 cytogenetics of, 8

gene recombination in, 6-7, 8-10 lactose fermentation and, 54-55, 88 mutation,

rates, 33 reverse, 399

polymixin resistance of, 36 radiation resistant, 13-14 resistant, 34, 89, 378-379

resting-cells? 377

(8)

streptomycin and, dependent, 398

resistant, 21, 31-32, 82, 83-84, 2 8 1 - 282, 343, 378, 382, 387, 3 8 8 - 390

sulfonamide resistant, 377-378, 397 Ethanol, see Alcohol

Ethylhydrocupreine, resistance to, 93 Euflavine, cytoplasmic inheritance and, 33 Euglena, streptomycin and, 343, 377, 410 Evipan, brain respiration and, 211-212 Evolution,

population interaction and, 411 variants and, 1

Eye,

morphine and, 225 tumor transplants and, 317

F

Fat, DDT toxicity and, 137-138, 152, 161-162

Feulgen reaction, bacteria and, 85-86 Flavin adenine dinucleotide, carcinogen

reduction and, 295 Flavoproteins,

acriflavine and, 91-93 cyanide resistance and, 142 drug resistance and, 396 Fleas, resistance of, 98 Flies,

chlordane resistant, 140 cross-resistance of, 148

DDT resistant, 135-136,137, 140, 142- 143, 161

origin of, 157

sensitivity of, 141-142 resistance of, 98 toxaphene resistant, 140 Fluctuation test, 411

drug resistance and, 52-54 factors affecting, 52-53 leukemia and, 342

proflavine resistance and, 91 validity of, 88, 89, 345-346

4'-Fluoroaminoazobenzene, carcinogenesis and, 289

Fluorophenylalanine, metabolism of, 367

resistance to, 366-367 Fluorophenylpyruvic acid, 367 5-Fluorotryptophan, resistance to, 367 Fluorotyrosines, resistance to, 367 Folic acid,

analogs,

absorption of, 275

azaguanine dependence and, 278 dependence on, 269-270 detoxification of, 275

nucleic acid synthesis and, 275-277 phosphate incorporation and, 276 conversion to citrovorum factor, 274,

275

drug antagonism of, 77 leukemias and, 273, 274 Formaldehyde,

carcinogens and, 294 mitosis and, 86

Formate, incorporation, folic analogs and, 276

Formic hydrogenlyase, nitrogen and, 394

streptomycin and, 387, 388, 398 Formic oxidase, streptomycin and, 387 Foulbrood, resistance to, 135 Fowl, domestication of, 168

Fructose, oxidation, narcotics and, 217 Fuchsin, see p-Rosaniline

Furadroxyl, resistance to, 32

G

Galactose, solanine and, 125-126, 127 Galactozymase, acridines and, 388 Garlic, herbicides and, 108

Gelatin, bacterial enzymes and, 393-394 Gelatinase, glycine and, 394

Genes, 417

blocked, protein and, 399-400 cytoplasmic, 410

drug resistance and, 24-25, 426-427

"leaky", 196

metabolic pathways and, 195-202 recombination,

bacterial, 31-32 resistance and, 424-425 suppressor, 360-361

(9)

Glucose,

alcohol and, 189 brain and, 210 oxidation, 218

narcotics and, 211-212, 217 solanine and, 125-126, 127 utilization,

nitrogen and, 394

streptomycin, 387-388, 398 sulfathiazole and, 397 tryptophan and, 386, 387 Glucuronidase, variations in, 200 Glutamic acid, 372

brain and, 210

influenza virus and, 372

oxidation, narcotics and, 212, 217 streptomycin resistance and, 390 sulfathiazole and, 387, 397 tobacco mosaic virus and, 372 Glutathione,

arsenic and, 139 DDT and, 150

drug resistance and, 63. 68, 69 Glyceraldehyde phosphate dehydrogen­

ase, drug resistance and, 395 Glycerol, adaptation, proflavine and, 4 7 -

48

Glycerophosphate, oxidation, narcotics and, 212

Glycine,

gelatinase and, 394 requirement for, 399 Glycogen, alcohol and, 189

Glycogenolysis, morphine and, 252-253 Glycolic acid, oxidation, herbicides and,

111 Glycolysis,

drugs and, 386

morphine and, 231-232

Gonadotropin, urinary, alcoholism and, 205

Grasses, herbicides and, 112, 118 Growth rate, drug resistance and, 82-83 Growth stage, herbicides and, 112-113 Guanine,

azaguanine and, 280

incorporation, leukemia and, 281 requirement for, 356-357

Guanylic acid, azaguanine and, 280 Η

Halides, hypersensitivity and, 401 Heart, morphine and, 225-226 Hemophilus pertussis, 7

drug resistance and, 382 Heptachlor,

metabolism of, 140 resistance to, 148, 155

l,4,5,6,7,8,8'-Heptachloro-3a,4,7,7a-tetra- hydro-4,7-methanoindane, see Hep­

tachlor

Herbicides, translocation of, 103-107 Heritability, degrees of, 167-168,173-174 Heroin, oxygen consumption and, 232 1,2,3,4,5,6-Hexachlorocyclohexane, see

Lindane

l,2,3,4,10,10-Hexachloro-6,7-epoxy-l,4,- 4a,5,6,7,8,8a-octahydro-l,4,5,6-dim- ethanonaphthalene, see Dieldrin l,2,3,4,10,10-Hexachloro-l,4,4a,5,8,8a- hexahydro-l,4,5,8-dimenthanonaph- thalene, see Aldrin

Hexatantalate, tartar emetic and, 68, 69, 70

Hippuric acid, urinary, alcoholism and, 205

Histamine,

morphine and, 252, 266 tolerance, development of, 265 Histaminase, histamine tolerance and, 265 Histidine,

requirement for, 398 streptomycin and, 390 synthesis of, 355

tobacco mosaic virus and, 372 Histidinol, 355

Homocysteine, threonine and, 358 Homoserine, threonine and 358 Hormones, variation in, 201

Hyamine-2389, herbicides and, 101-102 Hydrogenase, nitrogen and, 394 Hydroquinone, glycolysis and, 386 3-Hydroxy-4-acetylaminobiphenyl, carcin­

ogenesis and, 289-290

4-Hydroxy-3-aminoarsenosobenzene, drug resistance and, 71

(10)

Hydroxyanthranilic acid, accumulation of, 352, 355

4'-Hydroxy-4-dimethylaminoazobenzene, carcinogenesis and, 289

N-/?-Hydroxyethylmethylaminobenzene, carcinogenesis, and 289

Hydroxystreptomycin, cross-resistance and, 379

Hyperinsulinism, alcohol and, 205 Hypersensitivity, altered protein and, 4 0 1 -

402

Hypothalamus, alcoholism and, 413 Hypoxanthine, requirement for, 357

I Immunity,

tumors and, 315 antibodies, 326-328 antigens, 328-329 genetics, 313-315 nature of, 315-322 specificity, 322-326 transplantation and, 312

Imidazoles, histidine synthesis and, 355 Indol, tryptophan and, 353, 359

Indoleacetic acid, mechanism of action, 115, 116

Infections, bacterial, selection and, 171 Infiltration test, potato and, 123-124 Influenza,

control of, 335 mutants of, 372 Inheritance,

cytoplasmic, 425 environment and, 427 metabolic blocks and, 364-366 varietal characteristics and, 174 Insects, monophagous, adaptations of, 170 Invertase, nitrogen and, 394

Iodoacetate, DDT-dehydrochlorinase and, 163

IPC, see Isopropyl carbamate

1-Isomethadone, nerve morphology and, 231

Isoniazid,

p-aminosalicylic acid and, 36 dependence, 37

mutation rate and, 34

resistance, 10, 89 facultative, 35-36

Isopropyl carbamate, translocation of, 107 Κ

Kappa, 410, 418, 419

cytoplasmic inheritance and, 33 Kerosene, plant respiration and, 110 Ketobemidon, nerve morphology and, 231 α-Ketoisovaleric acid, accumulation of,

356

17-Ketosteroids, morphine and, 252 Kinetonucleus, see Parabasal body Klebsiella, drug antagonism in, 383 Kynurenic acid, accumulation of, 355

L Lactic acid,

brain activity and, 264 cyanide and, 386

oxidation, narcotics and, 211-212, 217 streptomycin and, 388

Lactic dehydrogenase, drug resistance and, 395

Lactobacillus, mercaptopurine and, 279, 280

Lactose, fermentation, 8, 11 Lag,

phenomic, 24-25 proflavine and, 43, 44 Lamarkianism, 426

drugs and, 409

Leafhoppers, resistance of, 98 Learning, fixation of, 420-421

Lecithin, morphine tolerance and, 230, 256

Lemna minor, dinitrocresol and, 103 Leptinotarsa decemlineata, see Beetle Leucine, polymixin resistance and, 391 Leukemias,

antimetabolites and, 268-269 azaguanine dependent, 278-279 cross-dependence of, 273 dependent,

azaguanine incorporation in, 280-281 diaminopurine incorporation in, 281 folic analog dependent, 269-277

(11)

formate incorporation and, 276 mercaptopurine and, 279 resistant,

mechanisms, 274-277 origin, 281-282

spontaneous, immunity and, 321 therapeutic considerations, 282-284 Lice,

DDT-dehydrochlorinase in, 156-157 resistance of, 98

transformations of, 169-170 Lindane,

detoxification of, 139 metabolism of, 140 resistance to, 148, 155—156 Lipase,

herbicides and, 111 variations in, 200 Lipids,

blood, variations in, 197-200 morphine and, 230

Locusts, phenol detoxification by, 140 Luminal, 220

brain respiration and, 211-212 potassium and, 215-217 Lycobiose, 126

tomatine and, 130

Lycotriose, constitution of, 130 Lysine,

influenza virus and, 372 requirement for, 360-361 streptomycin resistance and, 390 tobacco mosaic virus and, 372

Μ

MAB, see 4-Monomethylaminoazobenzene Magnamycin, bacterial mitosis and, 87 Malachite green, cross-resistance to, 379 Maleate, glycolysis and, 386

Maleic hydrazide, 100

Malonate, brain respiration and, 218 Mammals, winter coats of, 173 Mannitol, drug resistance and, 376 Mapharsen,

antagonism of, 69 resistance to, 62, 63, 66

MCP, see 2-Methyl-4-chlorophenoxyacetic acid

Medium, drug resistance and, 27-30, 389, 392-395

Melamine, see also Triethylene melamine drug antagonism and, 69

Melarsen,

antagonism of, 69-70 resistance to, 66

Meningococcus, streptomycin dependent, 397-398

Mercaptopurine,

A-methopterin and, 342 cross-dependence and, 278 leukemias and, 268-269, 271 resistance to, 279, 284

folic analogs and, 282 reversal of, 280

tumors and, 279

Meristem, herbicides and, 112-113 Mescaline,

spiders and, 420 tolerance and, 249 Meperidine,

enzyme action and, 237-238 excretion of, 235

morphine tolerance and, 228

morphological changes and, 258-260 Metabolism, genetic control of, 195-202 Metachloridine,

Paludrine and, 75 resistance to, 77

Metastasis, immunity and, 330-331 Methadone,

adrenal and, 231 excretion of, 235

morphine tolerance and, 228

morphological changes and, 258-260 nerve morphology and, 231

Methionine,

polymixin resistance and, 391 requirement for, 398

threonine and, 358

tobacco mosaic virus and, 372 Methopterin,

leukemias and, 273 utilization of, 277

Methoxychlor, resistance to, 148, 155 3'-Methylaminoazobenzene, carcinogene­

sis and, 289

(12)

2-Methyl-4-chlorophenoxyacetic acid, carbohydrate metabolism and, 109 enzymes and, 111

20-Methylcholanthrene,

carcinogen demethylation and, 295 carcinogen reduction and, 296 tumor inhibition and, 296

6-Methyldihydromorphine, nerve mor­

phology and, 231

2-Methyl-4-dimethylaminoazabenzene, carcinogenesis and, 303

Methyl-4-monomethylaminoazobenzene, demethylation of, 294

mitochondria and, 404 Methylene blue,

cross-resistance and, 379 resistance to, 47

9-Methylpteroylglutamic acid, leukemias and, 273

N10-Methylpteroylglutamic acid, see Meth- opterin

Micrococcus pyogenes, drug antagonism in, 383

streptomycin resistant, 376, 390-391 Mites, resistance of, 98

Mitochondria, 417-418 acridines and, 88, 93 brain activity and, 265 carcinogenesis and, 302, 404 inheritance and, 33

narcotics and, 230, 264 Mitosis,

bacterial, 86

2,4-dichlorophenoxyacetic acid and, 108 Modifications,

development of, 178 human posture and, 179

inheritance and, 175-176, 178-179 persistence of, 176, 178

Monocytes, sensitivity and, 401, 402, 403 4-Monomethylaminoazobenzene,

carcinogenesis and, 289 demethylation of, 289, 293 Morning glory, herbicides and, 108 Morphinan,

morphine tolerance and, 228

morphological changes and, 258-260 Morphine,

acute symptoms of, 259 antitoxin and, 238

cell permeability and, 255-256 cellular resistance to, 238-240 chronic symptoms, 259 coenzyme function and, 256

conjugation of, 234-235, 237, 253, 384, 405

cross-tolerance and, 228-230 dependence,

development of, 248-249 enzymes and, 415 signs of, 246-247

species differences and, 249-250 tolerance and, 225

diphasic action of, 239-240, 260-262 enzymes and, 256-257, 258

excretion, tolerances and, 233-236 morphological changes and, 258-260 nervous system and, 413-414 oxygen consumption and, 232, 251, 258 sedation and, 225

storage of, 236-237, 254 tolerance,

acute, 227-228 antitoxins and, 251-252 development of, 224-227 disappearance of, 227 mechanism of, 232-240

morphological and chemical changes, 230-232

toxicity of, 226

withdrawal of, 247, 248

Morphine monoglucuronide, drug toler­

ance and, 253

Mosquitoes, resistance of, 98, 135-136 Musca domestiea, see Flies

Mutagens,

drug resistance and, 409 responses to, 12-15 Mutants,

embryology of, 166 enzymes of, 398-399

multiple, requirements of, 359-362 Mutation,

direction of, 7-8, 10-12 drugs and, 409, 428-430 environment and, 419-420

(13)

evolution and, 1, 166, 174-176, 179- 180

frequency of, 7

inhibitions and, 356-358 multiple effects, 355-356 partial, 358-359 rates, 33-34

combination therapy and, 283-284

"reverse", 12, 37, 399 selection and, 412 spontaneous, 373-374 viability and, 165

Mutilation, inheritance and, 168-169 Mycobacterium ranae,

isoniazid dependent, 37 mutation rate,

isoniazid and, 34 streptomycin and, 33 Mycobacterium tuberculosis,

resistance to, 403

streptomycin resistant, 83, 84 Ν

Nalorphine, see N-Allynormorphine Naphthaleneacetic acid, 116

carbohydrate metabolism and, 108 ß-Naphthylamine, carcinogenesis and, 289 Naphuride, resistance to, 64, 66

Neoarsphenamine, resistance to, 66 Neomycin,

antagonism of, 383 cross-resistance and, 381 Nerve,

morphology, morphine and, 230-231 morphine and, 239-240, 250-251, 4 1 3 -

414 Neurospora,

adenine requirement of, 399 cytochromes of, 388

cytoplasmic inheritance in, 362-364 fluorophenylalanine resistant, 366-367 histidine and, 353-354

sulfanilamide and, dependent, 397-398, 399 resistant, 377

tryptophan and, 353 uridine requirement of, 399 vitamin requirement of, 398

Nicotinic acid, 203, 388 drug resistance and, 396 poky strain and, 363 synthesis of, 352-353

Night blue, cross resistance to, 379 Nitrogen mustards,

mutations and, 25 resistance to, 284

Normorphine, morphine and, 238, 254 Nucleases, carcinogens and, 302, 404 Nuclei, bacterial, 8

Nucleic acids, see also Deoxyribonucleic acid, Ribonucleic acid,

alloxan and, 47

carcinogenesis and, 302, 404 drug resistance and, 68, 69 immune reactions and, 371-372 poky strain and, 363

proflavine and, 47 specificity of, 371

synthesis, folic analogs and, 275-277 Nutrition, drug resistance and, 377-378

Ο

Oats, herbicides and, 112, 115-116 l,2,4,5,6,7,7,8,8-Octachloro-3a,4,7,7a-

tetrahydro-4,7-methanoindane, see Chlordane

Octamethylpyrophosphoramide, see OMPA

Octanoxidase, carcinogens and, 302, 404 OMPA,

metabolism of, 141 resistance to, 142 Onion, herbicides and, 108

Ophiostoma, purine requirement and, 356-357

Optochin, see Ethylhydrocupreine Organisms, environment and, 418 Organization, levels of 416-419

Oxalacetic oxidase, carcinogens and, 302, 404

Oxazine, cross-resistance and, 379 Oxydimorphine, morphine and antagon­

ism and, 237, 254 Oxygen,

toxicity of, 210-211 uptake, brain and, 209-210

(14)

466

Oxytetracycline, see Terramycin Ρ

Paludrine,

antagonists of, 77 resistance to, 73, 382

specificity, 74-77

Pamaquine, resistance to, 73, 74 Pantothenic acid,

alcoholism and, 204 requirement for, 398 sulfonamides and, 386-387 Parabasal body,

acridines and, 380

drug resistance and, 62, 72, 384 Paraldehyde, tolerance to, 229 Paramecium,

adaptation of, 78 antigenic variations in, 6 cytoplasmic inheritance and, 362 drug resistance of, 64, 378 kappa and, 410

modifications in, 174, 176-177 Paredrine, tolerance to, 229 Pasteur effect, narcotics and, 215 Pathogenicity, drug resistance and, 63 Pectin methoxylase, herbicides and, 111 Pediculus humanus, see Lice

Penicillin,

antagonistic drugs, 383

resistance to, 6, 32, 93, 376, 377, 382 loss of, 38

multistep, 34-35 resting cells and, 85 sensitivity to, 401 Penicillinase, 22, 384

drug resistance and, 376 production of, 27 Pentobarbital,

adenosine triphosphate and, 214 tolerance to, 239

Pentothal, brain respiration and, 218-219 Peptidases,

drug resistance and, 284 variations in, 200

Peptone, bacterial enzymes and, 394 Peroxides,

carcinogens and, 296

demethylation and, 294-295 PGA, see Folic acid

Phaseolus vulgaris, herbicides and, 107, 108, 111

Phenol,

colony form and, 49-50 detoxification of, 140 fluctuation test and, 54 resistance to, 88-89, 91-92 Phenol sulfatase, variations in, 200 Phenotype, drug resistance and, 26-27 Phenylalanine,

fluorophenylalanine and, 367 streptomycin and, 94-95, 390, 391 p-Phenylenediamine,

carcinogens and, 293 excretion of, 295

oxidation, narcotics and, 212 Phenylethylbarbiturate, see Luminal Phenylmethyl ureas, translocation of, 107 1-Phenylsemicarbazide, colony form and,

49, 50

Phloem, herbicide translocation and, 104-106

Phosphatase,

herbicides and, 111 variations in, 200 Phosphates,

high-energy, brain activity and, 265 incorporation, folic analogs and, 276 narcotics and, 264

streptomycin resistance and, 378 Phosphocreatine, brain and, 221 Phosphorylase, herbicides and, 111 Phosphorylation, uncoupling of, 264 Pig, domestication of, 168

Piperonyl cyclonene, DDT and, 140 Pituitary gland,

alcohol and, 185-186 morphine and, 225, 231, 252 Plant, epidermis, structure of, 100-101 Plasmodium, drug resistance of, 73-78,

382

Plastids, 410, 418 inheritance and, 33 Pneumococcus, 7

drug resistance in, 32, 93, 396 R-forms, 93

(15)

Polymixin,

cross-resistance to, 379

resistance to, 28, 36, 382, 391-393 Polyphosphate, accumulation of, 356 Polysaccharides,

herbicides and, 160 poky stain and, 363 Populations,

adaptations of, 421-422 environment and, 418-419 Potassium,

alcohol oxidation and, 219-220 barbiturates and, 215-217 brain respiration and, 217-218 morphine and, 231

Potato,

beetle resistant, 123 glycosides of, 124-128 Predator, prey-relationship, 413 Prodenia,

Pyrethrins and, 139 rotenone and, 138

Proflavine, see also Acridines absorption of, 45

adaptation, agar and, 48-49 development of, 55-56 fluctuation test and, 53 mechanisms of, 88 rate of, 45-46 stability of, 48 colony form and, 49-50 enzymes and, 43-44, 47-48 growth and, 43

nucleic acids and, 69 resistance, 37, 38, 87-88

fluctuation test and, 91 growth rate and, 92 replica plating and, 57 Proguanil, see Paludrine Proline,

streptomycin and, 387, 389, 390 requirements for, 360-361 Propamidine, resistance to, 45

stability of, 48 Protein,

altered,

antibody and, 400

carcinogenesis and, 403-405 hypersensitivity and, 401-402 narcotic addiction and, 405 carcinogen binding and, 296-301 carcinogenesis and, 302-305, 404 drug resistance and, 395-404 function, environment and, 417 mutations and, 398-399 Protozoa, drug resistance in, 26 Pseudomonas aeruginosa,

drug resistance in, 28, 378-379, 382 enzymes of, 393-395

polymixin resistant, 391

Pseudomorphine, see Oxydimorphine Pteroylglutamic acid, see Folic acid Pyrethrins, detoxification of, 139 Pyridoxal phosphate, tryptophan and, 353 Pyridoxine,

dependence, abnormal, 245 requirement for, 398

N^Pyrimidylsulfanilamide, see Sulfadia­

zine Pyronine,

cross-resistance and, 379 parabasal body and, 380 trypanosomes and, 62 Pyruvic acid,

accumulation of, 356 brain and, 210 oxidation, 218, 220

narcotics and, 211-212, 217, 266 utilization, 386

streptomycin and, 387, 389-390, 398 Pyruvic oxidase, oxygen and, 211

Q Quinine,

oxidation of, 384 resistance to, 73

Quinolines, resistance to, 64

Quinolinic acid, accumulation of, 355, 359 R

Racemorphan, nerve morphology and, 231

Radiations,

carcinogenesis and, 304 drug resistance and, 423-424

(16)

infection and, 346 mutations and, 381 resistance to, 13-14

gene recombination and, 424 specificity of, 14-15

tumor transplants and, 319-320, 344 Replica plating, 91-92

mutants and, 94-95 validity of, 89 Respiration,

herbicides and, 109-111 morphine and, 225, 226

Reticuloendothelial system, tumor trans­

plants and, 320

Rhamnose, solanine and, 125-126, 127 Rhodanate, morphine and, 258 Riboflavin, 388

alcoholism and, 204

carcinogenesis and, 295, 299, 302, 404 drug resistance and, 396

poky strain and, 363

requirement, temperature and, 358, 398 sulfonamides and, 386-387

Ribonucleic acid, influenza virus and, 372 Ribonucleoprotein,

inheritance and, 425 viruses and, 372

Ricin, sensitivity, inheritance of, 176 p-Rosaniline,

acriflavine and, 68, 69, 70 resistance, 61, 62, 66, 379

antibodies and, 73 Rotenone, excretion of, 138 Rous sarcoma virus, 372

S Saccharomyces,

irradiation of, 398 Salmonella, 7

colchicine and, 87 control of, 335 transduction and, 32 Saponin, resistance to, 177

Sarcoma, mercaptopurine and, 279, 284 Scale,

cyanide resistance of 142, 171-172 resistance of, 97, 135

Satellites, drug resistance and, 49, 50

Schradan, see OMPA Scurvy, alcohol and, 185-187

Sedation, morphine and, 224-225, 226, 227

Segregation, variations in, 177 Selazine, cross-resistance and, 379 Selection, evolution and, 166 Selenium, tolerance to, 99-100 Semicarbazide, 294

Sensitivity, collateral, 381 Serine,

aminoaxobenzenes and, 294 fluorophenylalanine and, 367 polymixin resistance and, 391 requirement for, 399

tryptophan and, 353, 359 Serratia, enzymes of, 393-394 Shikimic acid, inhibition and, 357-358 Sieve tubes, herbicide translocation and,

104-105

Smallpox, control of, 335

Sodium, urinary, alcoholism and, 205 Solabiose, structure of, 126

Solanidine, constitution of, 125 Solanines, 127

constitution of, 124-125 larvae and, 130

properties of, 125-126 toxicity of, 160

Solanum tuberosum, see Potato Solatriose, composition of, 126, 127 Solusalvarsan, resistance to, 66 Sonchus arvensis, herbicides and, 107 Southern bean mosaic virus, 372 Soybeans, herbicides and, 109 Spiders, drugs and, 420

Spleen, tumor transplants and, 316-317 Staphylococcus,

drug resistant, 376, 377, 378-379 penicillin resistance in, 6, 27, 34, 38 streptomycin resistant, 82, 83, 178 sulfathiazole and, 397

tryptophan and, 386-387 Stibonic acids, resistance to, 65 Stibosan, resistance to, 65 Stilbamidine, resistance to, 67, 78 4,4'-Stilbene-dicarboxamidine diisothion-

ate, resistance to, 67

(17)

Streptococcus,

drug antagonisms in, 383

folic antagonist resistant, 274-275 Streptomyces, irradiation of, 14 Streptomycin,

alternative pathways and, 428 antagonism to, 383

bacterial mitosis and, 87 cross-resistance to, 379, 381 dependence, 244, 397-398

variations in, 12 Escherichia coli and, 343 Euglena and, 343, 377, 410

mutation rate and, 15-17, 25, 94-95 pH and, 28

resistance, 32, 82-85, 89, 178, 376, 377, 378, 382

amino acids and, 387, 389, 390-391 facultative, 35-36

inheritance of, 9, 10, 11, 12 loss of, 37-38

multiple step, 34 mutation rate, 33, 381 prevalence, 14-15, 21 radiation and, 423-424 replica plating and, 57 specificity of, 90

Streptothricin, cross-resistance and, 381 Structure, determinism and, 416 Strychnine, tolerance and, 249 Succinate,

oxidation, 217 narcotics and, 212 proflavine adaptation and, 47 Succinic dehydrogenase, proflavine adap­

tation and, 47 Succinoxidase, 343

carcinogens and, 302, 404 Sucrose, fermentation of, 47 Sugar,

alcohol consumption and, 204-205 consumption, restriction of, 202 Sulfadiazine, 77

resistance to, 74, 75, 76, 382 Sulfanilamide, 3

dependence, 397-398, 399 resistance, 377, 382 threonine and, 358

Sulfathiazole,

pyruvate utilization and, 386 resistance to, 377-378, 397 Sulfonamides, see also specific drugs

antagonists of, 77 resistance to, 78, 379, 397 sensitivity to, 401

tryptophan utilization and, 386-387 Surfen C,

drug antagonism and, 69 resistance to, 66

Τ Tartar emetic,

resistance to, 62, 65, 66, 73, 97 antagonism of, 68, 69 sensitivity to, 70

Taurocholate, resistance to, 93 TCA, see Trichloroacetic acid Tellurite, resistance to, 45 TEM, see Triethylene melamine Temperature,

coat color and, 412 herbicides and, 102 morphine and, 226, 227 mutants and, 358

nutritional requirements and, 398-399 Tergitol-7, herbicides and, 101, 102 Terramycin,

antagonism to, 383 bacterial mitosis and, 87 penicillin and, 383

resistance to, 10, 32, 35, 78, 382, 430 Testis, tumor transplants and, 317 Tetraethylammonium, vasodilation and,

420

Tetraethylthiuram disulfide, see Anta­

buse Tetrahymena,

aminopterin and, 274-275 araguanine and, 280

Theobromine, caffeine tolerance and, 229 Theophylline, caffeine tolerance and, 229 Thiamine,

alcoholism and, 204 drug resistance and, 396 Thiazine

cross-resistance and, 379

(18)

resistance to, 396 Thioglycolic acid,

drug resistance and, 68 tartar emetic and, 70

Thioguanine, cross-dependence and, 278 Thionophosphates, metabolism of, 141 Thiopental, 220

excretion of, 236 tolerance to, 229, 239 Threonine, inhibition by, 358 Thrips, resistance of, 97

Thymine, incorporation, leukemia and, 281

Thymol,

colony form and, 50 fluctuation test and, 54 resistance, 51-52, 91 Thyroid gland,

coat color and, 412 morphine and, 231, 252 Tick, resistance of, 97

Tissue cultures, morphine and, 226-227, 250

Tobacco mosaic virus, amino acids of, 372 inheritance and, 425 mutants of, 372

Tomatidine, degradation of, 129 Tomatine,

constitution of, 128-130 larvae and, 124 Tomato,

alkaloid of. 128-130 herbicides and, 109, 116

Tomato bushy stunt virus, nucleoprotein and, 372

Toxaphene,

detoxification of, 140 resistance to, 98

Tradescantia palludosa, streptomycin and, 85

Transduction, drug resistance and, 32 Transforming agents, 7, 371

drug resistance and, 32 Translocation,

chemical structure and, 106-107 phloem and, 104-106

l,3,5-Triazinyl-2,4-diamino-6-p-amino- phenylarsonic acid, see Melarsen Trichloroacetic acid, translocation of, 107 1,1,1 -Trichloro-2,2-bis (p-methoxy-

phenyl) ethane, see Methoxychlor Trichlorophenoxyacetic acids,

activity of, 116 enzymes and, 111 translocation of, 106

Trichomonas vaginalis, drug resistance of, 78

Triethylene melamine, see also Melamine cross-dependence and, 278, 279 leukemias and, 271, 273

Triphenylmethane dyes, resistance to, 64 Triphosphopyridine nucleotide, carcino­

gens and, 294, 295 Tritons, herbicides and, 101 Trogoderma, DDT and, 142

Trypan blue, tumor transplants and, 320 Trypanosomes, 343

arsenic resistant, 379

drug resistant, 61-63, 66, 68, 70-72, 378, 384, 396

fuchsin resistant, 379 parabasal body, 380 Tryparosan, resistance to, 66

Tryparsamide, resistance to, 62, 71, 72 Tryptophan,

degradation of, 352-353 glucose utilization and, 386 influenza virus and, 372 synthesis, 353, 359

inhibitor of, 353-354

utilization, sulfathiazole and, 397 Tryptophan desmolase, multiple mutants

and, 360 Tuberculin,

sensitivity, 310

altered protein and, 402-403 antibody and, 401, 402 Tumors,

antigens of, 310-311

azaguanine incorporation in, 280 azo dye binding and, 300-301 diet and, 345

embryological resemblances, 344 establishment of, 320

(19)

extrinsic agents and, 326-327 filtrable agents and, 328-329 genetics and, 311-312, 313-315 herbicides and, 107

hyper susceptibility to, 321-322 immunization and, 314-315, 344

antibodies, 326-328 antigens, 328-329 genetics and, 313-315 nature of, 135-322 specificity of, 322-326 transplantation and, 312 regression of, 343-344 resistance to, 310

transplantation of, 310, 312, 316-317 Tween-20, herbicides and, 101

Tyrosine,

influenza virus and, 372 fluorophenylalanine and, 367 protease and, 394

U

Uric acid, alcoholism and, 205 Uricase, carcinogens and, 302, 404 Uridine,

requirement for, 360-361 temperature and, 399

Uridine diphosphate acetylaminosugar- peptide, 372

Ustilago maydis, streptomycin and, 85 V

Valine, 34

fluorophenylalanine and, 367 Variants, evolution and, 1

Vasoconstriction, behavior pattern and, 420

Viomycin,

bacterial mitosis and, 87 cross-resistance and, 381 Vinactin, cross-resistance and, 381 Viruses, 420

carcinogenesis and, 304 Viruses, plant, composition of, 372 Vitamin C, see Ascorbic acid

Vitamins, alcoholism and, 189-193, 2 0 6 - 208

W Wax, deposition of, 100-101 Weevil, DDT toxicity and, 138

Wetting agents, herbicide penetration and, 101-102

Wheat, herbicides and, 112, 115 Worms, resistance of, 98

X Xylose, tomatine and, 130

Y Yeast, 343

acridines and, 93, 376-377, 388, 425 cytoplasmic inheritance in, 362, 363 herbicides and, 103, 108, 109, 110, 117,

160

potato glycosides and, 131 Ζ

Zinc, enzymes and, 2

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

The template design concept was shown to be accurate (grade A, Gertzbein-Robbins scale) based on the comparison of the simulated surgery using the patient-specific physical model

It should be kept in mind that the mathematical method used for the estimation of purchase power in the catchment area can be sophisticated as it is, in

Just as Kaplan and Zingales (1997) argue, the definition of financial constraints is based on the cost of internal and external financing is the most precise one but also the

We modify the definition of the weighted integral mean so that we can com- pare two such means not only upon the main function but also upon the weight function.. As a consequence,

Article 12 of the Universal Declaration of Human Rights (United Nations, 1948), Article 17 of the International Covenant on Civil and Political Rights (United Nations, 1966),

Faculty of Social Sciences, Eötvös Loránd University Budapest (ELTE) Department of Economics, Eötvös Loránd University Budapest?. Institute of Economics, Hungarian Academy of Sciences

Thus the escape weights are built up, first assuming nominal or four stages of cryogenic propulsion, then considering the additive weight effects of going to minimum staging (two

In this section, we provide a brief overview of the relationship between CogInfoCom and various other fields in computing and cognitive sciences (i.e., affective comput- ing,